APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Plasma

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Blood Plasma Industry Growth and Trends Forecast to 2032

22 December 202591 pages

Choose your research edition.

Industry ResearchBlood Plasma Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Plasma Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Blood Plasma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Plasma Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Plasma Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Blood Plasma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood Plasma include Shanghai Raas, Baxter International, TCS Biosciences, Sanquin, Octapharma, Grifols, CSL, Cerus Corp and ADMA Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Blood Plasma market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Blood Plasma market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Blood Plasma market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Blood Plasma.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Blood Plasma market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Blood Plasma Market by Company

Shanghai Raas

Baxter International

TCS Biosciences

Sanquin

Octapharma

Grifols

CSL

Cerus Corp

ADMA Biologics

Blood Plasma Segment by Type

Protease Inhibitors

Coagulation Factor Concentrates

Immunoglobulin

Albumin

Others

Blood Plasma Segment by Application

Hospitals and Clinics

Research Laboratories

Academic Institutions

Blood Plasma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Blood Plasma manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Blood Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Protease Inhibitors Table 2. Major Company of Coagulation Factor Concentrates Table 3. Major Company of Immunoglobulin Table 4. Major Company of Albumin Table 5. Major Company of Others Table 6. Global Blood Plasma Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Blood Plasma Sales by Type (2021-2026) & (k units) Table 8. Global Blood Plasma Sales Market Share in Volume by Type (2021-2026) Table 9. Global Blood Plasma Sales by Type (2021-2026) & (US$ Million) Table 10. Global Blood Plasma Sales Market Share in Value by Type (2021-2026) Table 11. Global Blood Plasma Price by Type (2021-2026) & (US$/unit) Table 12. Global Blood Plasma Sales by Type (2027-2032) & (k units) Table 13. Global Blood Plasma Sales Market Share in Volume by Type (2027-2032) Table 14. Global Blood Plasma Sales by Type (2027-2032) & (US$ Million) Table 15. Global Blood Plasma Sales Market Share in Value by Type (2027-2032) Table 16. Global Blood Plasma Price by Type (2027-2032) & (US$/unit) Table 17. North America Blood Plasma Sales by Type (2021-2026) & (k units) Table 18. North America Blood Plasma Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Blood Plasma Sales by Type (2021-2026) & (k units) Table 20. Europe Blood Plasma Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Blood Plasma Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Blood Plasma Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Blood Plasma Sales by Type (2021-2026) & (k units) Table 24. Latin America Blood Plasma Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Blood Plasma Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Blood Plasma Sales by Type (2021-2026) & (US$ Million) Table 27. Blood Plasma Industry Trends Table 28. Blood Plasma Industry Drivers Table 29. Blood Plasma Industry Opportunities and Challenges Table 30. Blood Plasma Industry Restraints Table 31. Global Blood Plasma Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Blood Plasma Revenue Market Share by Company (2021-2026) Table 33. Global Blood Plasma Sales by Company (2021-2026) & (k units) Table 34. Global Blood Plasma Sales Share by Company (2021-2026) Table 35. Global Blood Plasma Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Blood Plasma Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Blood Plasma Major Company Production Sites and Headquarters Table 38. Global Blood Plasma Company, Product Type & Application Table 39. Global Blood Plasma Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Blood Plasma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Blood Plasma Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Blood Plasma Sales by Region (2021-2026) & (k units) Table 44. Global Blood Plasma Sales Market Share in Volume by Region (2021-2026) Table 45. Global Blood Plasma Sales by Region (2021-2026) & (US$ Million) Table 46. Global Blood Plasma Sales Market Share in Value by Region (2021-2026) Table 47. Global Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Blood Plasma Sales by Region (2027-2032) & (k units) Table 49. Global Blood Plasma Sales Market Share in Volume by Region (2027-2032) Table 50. Global Blood Plasma Sales by Region (2027-2032) & (US$ Million) Table 51. Global Blood Plasma Sales Market Share in Value by Region (2027-2032) Table 52. Global Blood Plasma Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Blood Plasma Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Blood Plasma Sales by Application (2021-2026) & (k units) Table 55. Global Blood Plasma Sales Market Share in Volume by Application (2021-2026) Table 56. Global Blood Plasma Sales by Application (2021-2026) & (US$ Million) Table 57. Global Blood Plasma Sales Market Share in Value by Application (2021-2026) Table 58. Global Blood Plasma Price by Application (2021-2026) & (US$/unit) Table 59. Global Blood Plasma Sales by Application (2027-2032) & (k units) Table 60. Global Blood Plasma Sales Market Share in Volume by Application (2027-2032) Table 61. Global Blood Plasma Sales by Application (2027-2032) & (US$ Million) Table 62. Global Blood Plasma Sales Market Share in Value by Application (2027-2032) Table 63. Global Blood Plasma Price by Application (2027-2032) & (US$/unit) Table 64. North America Blood Plasma Sales by Application (2021-2026) & (k units) Table 65. North America Blood Plasma Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Blood Plasma Sales by Application (2021-2026) & (k units) Table 67. Europe Blood Plasma Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Blood Plasma Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Blood Plasma Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Blood Plasma Sales by Application (2021-2026) & (k units) Table 71. Latin America Blood Plasma Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Blood Plasma Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Blood Plasma Sales by Application (2021-2026) & (US$ Million) Table 74. Shanghai Raas Company Information Table 75. Shanghai Raas Business Overview Table 76. Shanghai Raas Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Shanghai Raas Blood Plasma Product Portfolio Table 78. Shanghai Raas Recent Development Table 79. Baxter International Company Information Table 80. Baxter International Business Overview Table 81. Baxter International Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Baxter International Blood Plasma Product Portfolio Table 83. Baxter International Recent Development Table 84. TCS Biosciences Company Information Table 85. TCS Biosciences Business Overview Table 86. TCS Biosciences Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. TCS Biosciences Blood Plasma Product Portfolio Table 88. TCS Biosciences Recent Development Table 89. Sanquin Company Information Table 90. Sanquin Business Overview Table 91. Sanquin Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Sanquin Blood Plasma Product Portfolio Table 93. Sanquin Recent Development Table 94. Octapharma Company Information Table 95. Octapharma Business Overview Table 96. Octapharma Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Octapharma Blood Plasma Product Portfolio Table 98. Octapharma Recent Development Table 99. Grifols Company Information Table 100. Grifols Business Overview Table 101. Grifols Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Grifols Blood Plasma Product Portfolio Table 103. Grifols Recent Development Table 104. CSL Company Information Table 105. CSL Business Overview Table 106. CSL Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. CSL Blood Plasma Product Portfolio Table 108. CSL Recent Development Table 109. Cerus Corp Company Information Table 110. Cerus Corp Business Overview Table 111. Cerus Corp Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Cerus Corp Blood Plasma Product Portfolio Table 113. Cerus Corp Recent Development Table 114. ADMA Biologics Company Information Table 115. ADMA Biologics Business Overview Table 116. ADMA Biologics Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. ADMA Biologics Blood Plasma Product Portfolio Table 118. ADMA Biologics Recent Development Table 119. North America Blood Plasma Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. North America Blood Plasma Sales by Country (2021-2026) & (k units) Table 121. North America Blood Plasma Sales Market Share by Country (2021-2026) Table 122. North America Blood Plasma Sales Forecast by Country (2027-2032) & (k units) Table 123. North America Blood Plasma Sales Market Share Forecast by Country (2027-2032) Table 124. North America Blood Plasma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Blood Plasma Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Blood Plasma Market Share by Country (2021-2026) Table 127. North America Blood Plasma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Blood Plasma Market Share Forecast by Country (2027-2032) Table 129. Europe Blood Plasma Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Europe Blood Plasma Sales by Country (2021-2026) & (k units) Table 131. Europe Blood Plasma Sales Market Share by Country (2021-2026) Table 132. Europe Blood Plasma Sales Forecast by Country (2027-2032) & (k units) Table 133. Europe Blood Plasma Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Blood Plasma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Blood Plasma Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Blood Plasma Market Share by Country (2021-2026) Table 137. Europe Blood Plasma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Blood Plasma Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Blood Plasma Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Blood Plasma Sales by Country (2021-2026) & (k units) Table 141. Asia-Pacific Blood Plasma Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Blood Plasma Sales Forecast by Country (2027-2032) & (k units) Table 143. Asia-Pacific Blood Plasma Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Blood Plasma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Blood Plasma Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Blood Plasma Market Share by Country (2021-2026) Table 147. Asia-Pacific Blood Plasma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Blood Plasma Market Share Forecast by Country (2027-2032) Table 149. Latin America Blood Plasma Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Latin America Blood Plasma Sales by Country (2021-2026) & (k units) Table 151. Latin America Blood Plasma Sales Market Share by Country (2021-2026) Table 152. Latin America Blood Plasma Sales Forecast by Country (2027-2032) & (k units) Table 153. Latin America Blood Plasma Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Blood Plasma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Blood Plasma Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Blood Plasma Market Share by Country (2021-2026) Table 157. Latin America Blood Plasma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Blood Plasma Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Blood Plasma Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Blood Plasma Sales by Country (2021-2026) & (k units) Table 161. Middle East and Africa Blood Plasma Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Blood Plasma Sales Forecast by Country (2027-2032) & (k units) Table 163. Middle East and Africa Blood Plasma Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Blood Plasma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Blood Plasma Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Blood Plasma Market Share by Country (2021-2026) Table 167. Middle East and Africa Blood Plasma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Blood Plasma Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Blood Plasma Distributors List Table 172. Blood Plasma Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Blood Plasma Image Figure 2. Global Blood Plasma Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Plasma Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Plasma Sales (2021-2032) & (k units) Figure 5. Protease Inhibitors Image Figure 6. Global Protease Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 7. Coagulation Factor Concentrates Image Figure 8. Global Coagulation Factor Concentrates Sales YoY Growth (2021-2032) & (k units) Figure 9. Immunoglobulin Image Figure 10. Global Immunoglobulin Sales YoY Growth (2021-2032) & (k units) Figure 11. Albumin Image Figure 12. Global Albumin Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Blood Plasma Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Blood Plasma Market Share by Type 2025 VS 2032 Figure 17. North America Blood Plasma Sales Market Share in Volume by Type in 2025 Figure 18. North America Blood Plasma Sales Market Share in Value by Type in 2025 Figure 19. Europe Blood Plasma Sales Market Share in Volume by Type in 2025 Figure 20. Europe Blood Plasma Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Blood Plasma Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Blood Plasma Sales Market Share in Value by Type in 2025 Figure 23. Latin America Blood Plasma Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Blood Plasma Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Blood Plasma Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Blood Plasma Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Blood Plasma Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospitals and Clinics Image Figure 30. Global Hospitals and Clinics Sales YoY Growth (2021-2032) & (k units) Figure 31. Research Laboratories Image Figure 32. Global Research Laboratories Sales YoY Growth (2021-2032) & (k units) Figure 33. Academic Institutions Image Figure 34. Global Academic Institutions Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Blood Plasma Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Blood Plasma Market Share by Application 2025 VS 2032 Figure 37. North America Blood Plasma Sales Market Share in Volume by Application in 2025 Figure 38. North America Blood Plasma Sales Market Share in Value by Application in 2025 Figure 39. Europe Blood Plasma Sales Market Share in Volume by Application in 2025 Figure 40. Europe Blood Plasma Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Blood Plasma Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Blood Plasma Sales Market Share in Value by Application in 2025 Figure 43. Latin America Blood Plasma Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Blood Plasma Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Blood Plasma Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Blood Plasma Sales Market Share in Value by Application in 2025 Figure 47. North America Blood Plasma Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Blood Plasma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Blood Plasma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Blood Plasma Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Blood Plasma Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Blood Plasma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Blood Plasma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Blood Plasma Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Blood Plasma Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Blood Plasma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Blood Plasma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Blood Plasma Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Blood Plasma Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Blood Plasma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Blood Plasma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Blood Plasma Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Blood Plasma Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Blood Plasma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Blood Plasma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Blood Plasma Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Blood Plasma Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Blood Plasma Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Protease Inhibitors
  • Coagulation Factor Concentrates
  • Immunoglobulin
  • Albumin
  • Others
Applications
  • Hospitals and Clinics
  • Research Laboratories
  • Academic Institutions
Companies covered
  • Shanghai Raas
  • Baxter International
  • TCS Biosciences
  • Sanquin
  • Octapharma
  • Grifols
  • CSL
  • Cerus Corp
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood Plasma Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Blood Plasma Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Blood Plasma Market by Type
  6. 1.3.1 Protease Inhibitors
  7. 1.3.2 Coagulation Factor Concentrates
  8. 1.3.3 Immunoglobulin
  9. 1.3.4 Albumin
  10. 1.3.5 Others
  11. 1.4 Global Blood Plasma Market Size by Type
  12. 1.4.1 Global Blood Plasma Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Blood Plasma Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Blood Plasma Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Blood Plasma Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Blood Plasma Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Blood Plasma Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Blood Plasma Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Blood Plasma Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Blood Plasma Industry Trends
  2. 2.2 Blood Plasma Industry Drivers
  3. 2.3 Blood Plasma Industry Opportunities and Challenges
  4. 2.4 Blood Plasma Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Blood Plasma Revenue (2021-2026)
  2. 3.2 Global Top Players by Blood Plasma Sales (2021-2026)
  3. 3.3 Global Top Players by Blood Plasma Price (2021-2026)
  4. 3.4 Global Blood Plasma Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Blood Plasma Major Company Production Sites & Headquarters
  6. 3.6 Global Blood Plasma Company, Product Type & Application
  7. 3.7 Global Blood Plasma Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Blood Plasma Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Blood Plasma Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Blood Plasma Tier 1, Tier 2, and Tier 3
4 Blood Plasma Regional Status and Outlook
  1. 4.1 Global Blood Plasma Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Blood Plasma Historic Market Size by Region
  3. 4.2.1 Global Blood Plasma Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Blood Plasma Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Blood Plasma Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Blood Plasma Forecasted Market Size by Region
  7. 4.3.1 Global Blood Plasma Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Blood Plasma Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Blood Plasma Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Blood Plasma by Application
  1. 5.1 Blood Plasma Market by Application
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Research Laboratories
  4. 5.1.3 Academic Institutions
  5. 5.2 Global Blood Plasma Market Size by Application
  6. 5.2.1 Global Blood Plasma Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Blood Plasma Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Blood Plasma Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Blood Plasma Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Blood Plasma Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Blood Plasma Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Blood Plasma Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Blood Plasma Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai Raas
  2. 6.1.1 Shanghai Raas Company Information
  3. 6.1.2 Shanghai Raas Business Overview
  4. 6.1.3 Shanghai Raas Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai Raas Blood Plasma Product Portfolio
  6. 6.1.5 Shanghai Raas Recent Developments
  7. 6.2 Baxter International
  8. 6.2.1 Baxter International Company Information
  9. 6.2.2 Baxter International Business Overview
  10. 6.2.3 Baxter International Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Baxter International Blood Plasma Product Portfolio
  12. 6.2.5 Baxter International Recent Developments
  13. 6.3 TCS Biosciences
  14. 6.3.1 TCS Biosciences Company Information
  15. 6.3.2 TCS Biosciences Business Overview
  16. 6.3.3 TCS Biosciences Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 TCS Biosciences Blood Plasma Product Portfolio
  18. 6.3.5 TCS Biosciences Recent Developments
  19. 6.4 Sanquin
  20. 6.4.1 Sanquin Company Information
  21. 6.4.2 Sanquin Business Overview
  22. 6.4.3 Sanquin Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanquin Blood Plasma Product Portfolio
  24. 6.4.5 Sanquin Recent Developments
  25. 6.5 Octapharma
  26. 6.5.1 Octapharma Company Information
  27. 6.5.2 Octapharma Business Overview
  28. 6.5.3 Octapharma Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Octapharma Blood Plasma Product Portfolio
  30. 6.5.5 Octapharma Recent Developments
  31. 6.6 Grifols
  32. 6.6.1 Grifols Company Information
  33. 6.6.2 Grifols Business Overview
  34. 6.6.3 Grifols Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Grifols Blood Plasma Product Portfolio
  36. 6.6.5 Grifols Recent Developments
  37. 6.7 CSL
  38. 6.7.1 CSL Company Information
  39. 6.7.2 CSL Business Overview
  40. 6.7.3 CSL Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CSL Blood Plasma Product Portfolio
  42. 6.7.5 CSL Recent Developments
  43. 6.8 Cerus Corp
  44. 6.8.1 Cerus Corp Company Information
  45. 6.8.2 Cerus Corp Business Overview
  46. 6.8.3 Cerus Corp Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cerus Corp Blood Plasma Product Portfolio
  48. 6.8.5 Cerus Corp Recent Developments
  49. 6.9 ADMA Biologics
  50. 6.9.1 ADMA Biologics Company Information
  51. 6.9.2 ADMA Biologics Business Overview
  52. 6.9.3 ADMA Biologics Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ADMA Biologics Blood Plasma Product Portfolio
  54. 6.9.5 ADMA Biologics Recent Developments
7 North America by Country
  1. 7.1 North America Blood Plasma Sales by Country
  2. 7.1.1 North America Blood Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Blood Plasma Sales by Country (2021-2026)
  4. 7.1.3 North America Blood Plasma Sales Forecast by Country (2027-2032)
  5. 7.2 North America Blood Plasma Market Size by Country
  6. 7.2.1 North America Blood Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Blood Plasma Market Size by Country (2021-2026)
  8. 7.2.3 North America Blood Plasma Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Blood Plasma Sales by Country
  2. 8.1.1 Europe Blood Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Blood Plasma Sales by Country (2021-2026)
  4. 8.1.3 Europe Blood Plasma Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Blood Plasma Market Size by Country
  6. 8.2.1 Europe Blood Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Blood Plasma Market Size by Country (2021-2026)
  8. 8.2.3 Europe Blood Plasma Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Blood Plasma Sales by Country
  2. 9.1.1 Asia-Pacific Blood Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Blood Plasma Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Blood Plasma Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Blood Plasma Market Size by Country
  6. 9.2.1 Asia-Pacific Blood Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Blood Plasma Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Blood Plasma Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Blood Plasma Sales by Country
  2. 10.1.1 South America Blood Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Blood Plasma Sales by Country (2021-2026)
  4. 10.1.3 South America Blood Plasma Sales Forecast by Country (2027-2032)
  5. 10.2 South America Blood Plasma Market Size by Country
  6. 10.2.1 South America Blood Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Blood Plasma Market Size by Country (2021-2026)
  8. 10.2.3 South America Blood Plasma Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Blood Plasma Sales by Country
  2. 11.1.1 Middle East and Africa Blood Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Blood Plasma Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Blood Plasma Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Blood Plasma Market Size by Country
  6. 11.2.1 Middle East and Africa Blood Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Blood Plasma Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Blood Plasma Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Blood Plasma Value Chain Analysis
  2. 12.1.1 Blood Plasma Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Blood Plasma Production Mode & Process
  7. 12.2 Blood Plasma Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Blood Plasma Distributors
  10. 12.2.3 Blood Plasma Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst